ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Multicenter Randomized Clinical Investigation for the Safety and Efficacy of Advagraf® (Extended-Release Tacrolimus) vs. Prograf® (Twice-Daily Tacrolimus) in De Novo Korean Adult Kidney Recipients

C. Oh, K. Huh, J. Lee, J. Lee, H. Cho, Y. Kim

Department of Surgery, Ajou University School of Medicine, Suwon, Kyonggi Province, Korea
Department of Surgery, Yonsei University College of Medicine, Seoul, Korea
Department of Nephrology, University of Ulsan, Ulsan, Korea
Department of Surgery, University of Ulsan, Ulsan, Korea

Meeting: 2013 American Transplant Congress

Abstract number: B954

Related Abstracts
  • Efficacy, Safety and Pharmacokinetics of Once-Daily, MeltDose® Tacrolimus (Envarsus® XR) Versus Twice-Daily Tacrolimus (Prograf®) in De Novo Kidney Transplant Recipient Sub-Groups: A 2 Year Phase 3 Randomized, Double-Blind, Double-Dummy, Trial
  • Phase 3, Double-Blind, Multi-Center, Non-Inferiority, Randomized Study To Examine the Efficacy and Safety of LCP-Tacro™ Tablets, Once Daily, Compared to Prograf® Capsules, Twice Daily, in Combination with Mycophenolate Mofetil in De Novo Adult Kidney Transplantation: Baseline Characteristics, A

Introduction: Successful outcome in renal transplantation definitely depends on patient’s compliance with immunosuppressive medications. Compliance with complex immunosuppressive drugs might be improved with regimen that requires less frequent dosing, if the regimen would be safe and effective to prevent acute rejection. The purpose of this study is to compare the safety, efficacy, and patient satisfaction of once-a-day tacrolimus with twice-daily tacrolimus.

Methods: This prospective, randomized, open-label, multicenter study was conducted at three institutes. The patients of the investigational group were converted to the same daily dose of extended-release tacrolimus once a day AM after 1 month post-transplantation, while the patients in control group were kept the dosing of tacrolimus twice a day. We evaluated the efficacy, safety, and patient satisfaction of the groups within 6 months post-transplantation.

Results: Sixty patients were enrolled and randomized into the investigational group (28 of 29 patients completed the study follow-up) and the control group (26 of 31 patients completed the study follow-up). Within 5 months after conversion, the incidence of biopsy-confirmed acute rejection of the investigational group was 0%, compared with 10.7% of the control group; patient survival was 100% in each group. We could not find the differences of the patients’ eGFR at 6 months post-transplantation between the groups (P=0.97). The safety profile and satisfaction profile (Immunosuppressant Therapy Barrier Scale; ITBS) were consistent with the group of the twice-daily tacrolimus (P=0.35).

Conclusion: The results of this study support the safety, efficacy, and patient satisfaction of once-a-day tacrolimus, compared to twice-daily tacrolimus.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Oh C, Huh K, Lee J, Lee J, Cho H, Kim Y. Multicenter Randomized Clinical Investigation for the Safety and Efficacy of Advagraf® (Extended-Release Tacrolimus) vs. Prograf® (Twice-Daily Tacrolimus) in De Novo Korean Adult Kidney Recipients [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/multicenter-randomized-clinical-investigation-for-the-safety-and-efficacy-of-advagraf-extended-release-tacrolimus-vs-prograf-twice-daily-tacrolimus-in-de-novo-korean-adult-kidney-recipi/. Accessed February 25, 2021.

« Back to 2013 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Home
  • Search
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.